Embolic stroke of undetermined source (ESUS)
Conditions
Interventions
None listed
Sponsors
The University of Osaka Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who experienced an ischemic stroke between January 2021 and April 2025 and visited or were admitted to the participating institution. 2. Patients diagnosed with embolic stroke of undetermined source.
Exclusion criteria
Exclusion criteria: Patients who did not consent to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Incidence of recurrent stroke during follow-up 2. Characteristics of patients with implantable loop recorders or electrocardiogram patch monitors 3. Timing of atrial fibrillation detection and atrial fibrillation burden | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Timing of atrial fibrillation detection and AF burden after PFO closure 2. Antithrombotic therapy and ischemic or bleeding events after percutaneous PFO closure | — |
Countries
Japan
Contacts
Public ContactJunji Takasugi
The University of Osaka Graduate School of Medicine Department of Neurology
Outcome results
None listed